Advanced in Primary Immunodeficiency (PID)

Marlene Pasquet

Toulouse, FR 
Advanced in Primary Immunodeficiency (PID)
Toulouse, FR 
OverviewLocationsClinical Research

Overview

Marlene Pasquet practices in Toulouse, France. Ms. Pasquet is rated as an Advanced expert by MediFind in the treatment of Primary Immunodeficiency (PID). Her top areas of expertise are Evans Syndrome, Autoimmune Hemolytic Anemia, Adenosine Deaminase Deficiency, Splenectomy, and Vaginectomy.

Her clinical research consists of co-authoring 93 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 8 articles and participated in 1 clinical trial in the study of Primary Immunodeficiency (PID).

Gender
Female

Locations

Toulouse, France
Other Locations
Eu, France
CHU de Montpellier
Montpellier, France
Bordeaux, France
Reims, France
Orsay, 91405, France
CHU Grenoble Alpes
Grenoble, France
CHU
Saint-etienne-de-valoux, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase I Study of Fluvastatin-Celebrex Association for Optico-chiasmatic Low Grade Gliomas and High Grade Gliomas Localized Outside the Brainstem, Relapsed or Refactory, in Children or Young Adults
Phase I Study of Fluvastatin-Celebrex Association for Optico-chiasmatic Low Grade Gliomas and High Grade Gliomas Localized Outside the Brainstem, Relapsed or Refactory, in Children or Young Adults
Enrollment Status: Completed
Publish Date: February 10, 2022
Intervention Type: Drug
Study Drugs: Fluvastatine, Celebrex
Study Phase: Phase 1
Evaluation of the Clinical Utility and Cost Effectiveness Ratio of Generalized Neonatal Screening for Severe Combined Immunodeficiencies (SCID) by Quantification of TRECs on Guthrie Cards
Evaluation of the Clinical Utility and Cost Effectiveness Ratio of Generalized Neonatal Screening for Severe Combined Immunodeficiencies (SCID) by Quantification of TRECs on Guthrie Cards
Enrollment Status: Completed
Publish Date: July 24, 2018
Intervention Type: Biological
Study Phase: Not Applicable
Feasibility Study of a Treatment Protocol of Pediatric Chemo- and Radiotherapy-induced Oral Mucositis by Low-level Laser Therapy
Feasibility Study of a Treatment Protocol of Pediatric Chemo- and Radiotherapy-induced Oral Mucositis by Low-level Laser Therapy
Enrollment Status: Completed
Publish Date: May 31, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trials

93 Total Publications

Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: A propensity score-matched study.
Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: A propensity score-matched study.
Journal: Blood advances
Published: June 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Pasquet's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 39 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile